Trial
NCT06290765
Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
PharmaEssentia
Collaborators
—
Condition
Polycythemia Vera
Intervention
Ropeginterferon alfa-2b
Why stopped
In alignment with company strategic direction.
Provenance
Dataset: 2026-07-31 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-31